Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population

Li,Miao; Chen,Rong; Ji,Baoyan; Fan,Chunmei; Wang,Guanying; Yue,Chenli; Jin,Guoquan

doi:10.3892/or.2021.7935

Role of ERCC5 polymorphisms in non‑small cell lung cancer risk and responsiveness/toxicity to cisplatin‑based chemotherapy in the Chinese population

Authors:
- Miao Li
- Rong Chen
- Baoyan Ji
- Chunmei Fan
- Guanying Wang
- Chenli Yue
- Guoquan Jin
View Affiliations

Affiliations: Department of Medicine Oncology, The Fifth People's Hospital of Qinghai Province, Xining, Qinghai 810007, P.R. China, Department of Medicine Oncology, The Affiliated Hospital of Qinghai University, Xining, Qinghai 810016, P.R. China, Department of Science and Education, The Fifth People's Hospital of Qinghai Province, Xining, Qinghai 810007, P.R. China, Department of Oncology, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Respiratory Medicine, Shaanxi Provincial Corps Hospital of Chinese People's Armed Police Force, Xi'an, Shaanxi 710054, P.R. China
Published online on: January 14, 2021 https://doi.org/10.3892/or.2021.7935
Pages: 1295-1305

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Non‑small cell lung cancer (NSCLC) is the leading cause of cancer‑related deaths worldwide. Cisplatin‑based chemotherapy currently represents the main treatment option for patients with NSCLC. The aim of the present study was to evaluate effect of single nucleotide polymorphisms (SNPs) within the excision repair cross‑complementing group 5 (ERCC5) gene on susceptibility to NSCLC, as well as the responsiveness to and toxicity of cisplatin chemotherapy. A total of 506 patients with NSCLC and 510 healthy controls were recruited for the present study. All DNA samples were genotyped by the Agena MassARRAY platform. Logistic regression analysis was carried out to assess the relationship between ERCC5 polymorphisms with NSCLC susceptibility and responsiveness to chemotherapy. The rs4771436 TG‑GG genotype was associated with increased NSCLC risk. When the data were stratified according to age, sex, tobacco smoking, body mass index and histological type, ERCC5 polymorphisms (rs2016073, rs4771436, rs11069498 and rs4150330) were associated with NSCLC risk. Furthermore, the A allele and GA‑AA genotype of rs11069498 were related to the response to chemotherapy. ERCC5 (rs11069498 and rs4150330) polymorphisms were associated with the increased risk of toxicity. However, rs4771436 in ERCC5 gene was significantly correlated with the reduced risk of toxicity. These results suggested a potential relationship between ERCC5 polymorphisms, the risk of NSCLC and the sensitivity to cisplatin‑based chemotherapy among Chinese populations.

View Figures

View References

1	Gao ZJ, Yuan WD, Yuan JQ, Yuan K and Wang Y: Downregulation of HIF-2α reverse the chemotherapy resistance of lung adenocarcinoma A549 cells to cisplatin. Med Sci Monit. 24:1104–1111. 2018. View Article : Google Scholar : PubMed/NCBI
2	Chen JB, Wang F, Wu JJ and Cai M: Glutathione S-transferase pi polymorphism contributes to the treatment outcomes of advanced non-small cell lung cancer patients in a Chinese population. Genet Mol Res. 25:152016.
3	Zhang LP, Wang CP, Li LH, Tang YF and Li WC: The interaction between smoking and CYP1A1 mspI polymorphism on lung cancer: A meta-analysis in the Chinese population. Eur J Cancer Care. 26:doi:10. 2017. View Article : Google Scholar
4	Shields PG: Molecular epidemiology of smoking and lung cancer. Oncogene. 21:6870–6876. 2002. View Article : Google Scholar : PubMed/NCBI
5	Hu QY, Jin TB, Wang L, Zhang L, Geng T, Liang G and Kang LL: Genetic variation in the TP63 gene is associated with lung cancer risk in the han population. Tumour Biol. 35:1863–1866. 2014. View Article : Google Scholar : PubMed/NCBI
6	Gao L, Thakur A, Liang Y, Zhang S, Wang T, Chen T, Meng J, Wang L, Wu F and Jin T: Polymorphisms in the TERT gene are associated with lung cancer risk in the Chinese han population. Eur J Cancer Prev. 23:497–501. 2014. View Article : Google Scholar : PubMed/NCBI
7	Liang Y, Deng J, Xiong Y, Wang S and Xiong W: Genetic association between ERCC5 rs17655 polymorphism and lung cancer risk: Evidence based on a meta-analysis. Tumour Biol. 35:5613–5618. 2014. View Article : Google Scholar : PubMed/NCBI
8	Wang T, Chen T, Thakur A, Liang Y, Gao L, Zhang S, Tian Y, Jin T, Liu JJ and Chen M: Association of PSMA4 polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a chinese han population. Clin Transl Oncol. 17:564–569. 2015. View Article : Google Scholar : PubMed/NCBI
9	Cheng J, Ha M, Wang Y, Sun J, Chen J, Wang Y and Tong C: A C118T polymorphism of ERCC1 and response to cisplatin chemotherapy in patients with late-stage non-small cell lung cancer. J Cancer Res Clin Oncol. 138:231–238. 2012. View Article : Google Scholar : PubMed/NCBI
10	Bu L, Zhang LB, Mao X and Wang P: GSTP1 Ile105Val and XRCC1 Arg399Gln gene polymorphisms contribute to the clinical outcome of patients with advanced non-small cell lung cancer. Genet Mol Res. Jun 3–2016.(Epub ahead of print). doi: 10.4238/gmr.15027611. View Article : Google Scholar : PubMed/NCBI
11	Liu D, Wu J, Shi GY, Zhou HF and Yu Y: Role of XRCC1 and ERCC5 polymorphisms on clinical outcomes in advanced non-small cell lung cancer. Genet Mol Res. 13:3100–3107. 2014. View Article : Google Scholar : PubMed/NCBI
12	Wang H, Gao X, Zhang X, Gong W, Peng Z, Wang B, Wang L, Chang S, Ma P and Wang S: Glutathione S-transferase gene polymorphisms are associated with an improved treatment response to cisplatin-based chemotherapy in patients with non-small cell lung cancer (NSCLC): A meta-analysis. Med Sci Monit. 24:7482–7492. 2018. View Article : Google Scholar : PubMed/NCBI
13	Fritz A, Percy C and Jack A: International Classification of Diseases for Oncology. 3rd edition. World Health Organization; Geneva: 2000
14	Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P and Popanda O: Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer. 125:1431–1439. 2009. View Article : Google Scholar : PubMed/NCBI
15	Ramirez JL, Rosell R, Taron M, Sanchez-Ronco M, Alberola V, de Las Peñas R, Sanchez JM, Moran T, Camps C and Massuti B: 14-3-3sigma methylation in pretreatment serum circulating DNA of cisplatin-plus-gemcitabine-treated advanced non-small-cell lung cancer patients predicts survival: The Spanish Lung Cancer Group. J Clin Oncol. 23:9105–9112. 2005. View Article : Google Scholar : PubMed/NCBI
16	Liang Y, Thakur A, Gao L, Wang T, Zhang S, Ren H, Meng J, Geng T, Jin T and Chen M: Correlation of CLPTM1L polymorphisms with lung cancer susceptibility and response to cisplatin-based chemotherapy in a chinese han population. Tumour Biol. 35:12075–12082. 2014. View Article : Google Scholar : PubMed/NCBI
17	Perez-Ramirez C, Canadas-Garre M, Molina MA, Robles AI, Faus-Dader MJ and Calleja-Hernandez MA: Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer. Mutat Res. 771:32–58. 2017. View Article : Google Scholar : PubMed/NCBI
18	Rulli E, Guffanti F, Caiola E, Ganzinelli M, Damia G, Garassino MC, Piva S, Ceppi L, Broggini M and Marabese M: The 5′UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs. Sci Rep. 6:392172016. View Article : Google Scholar : PubMed/NCBI
19	Vrouwe MG, Pines A, Overmeer RM, Hanada K and Mullenders LH: UV–Induced photolesions elicit ATR-kinase-dependent signaling in non-cycling cells through nucleotide excision repair-dependent and -independent pathways. J Cell Sci. 124:435–446. 2011. View Article : Google Scholar : PubMed/NCBI
20	Weiss JM, Weiss NS, Ulrich CM, Doherty JA and Chen C: Nucleotide excision repair genotype and the incidence of endometrial cancer: Effect of other risk factors on the association. Gynecol Oncol. 103:891–896. 2006. View Article : Google Scholar : PubMed/NCBI
21	Scharer OD: XPG: Its products and biological roles. Adv Exp Med Biol. 637:83–92. 2008. View Article : Google Scholar : PubMed/NCBI
22	Na N, Dun E, Ren L and Li G: Association between ERCC5 gene polymorphisms and breast cancer risk. Int J Clin Exp Pathol. 8:3192–3197. 2015.PubMed/NCBI
23	Guo BW, Yang L, Zhao R and Hao SZ: Association between ERCC5 gene polymorphisms and gastric cancer risk. Genet Mol Res. 15:doi:10.4238, 2016.
24	Li X, Zhang J, Su C, Zhao X, Tang L and Zhou C: The association between polymorphisms in the DNA nucleotide excision repair genes and RRM1 gene and lung cancer risk. Thorac Cancer. 3:239–248. 2012. View Article : Google Scholar : PubMed/NCBI
25	He C, Duan Z, Li P, Xu Q and Yuan Y: Role of ERCC5 promoter polymorphisms in response to platinum-based chemotherapy in patients with advanced non-small-cell lung cancer. Anticancer Drugs. 24:300–305. 2013. View Article : Google Scholar : PubMed/NCBI
26	Huang D and Zhou Y: Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies. Biomed Rep. 2:452–462. 2014. View Article : Google Scholar : PubMed/NCBI
27	Sullivan I, Salazar J, Majem M, Pallares C, Del Rio E, Paez D, Baiget M and Barnadas A: Pharmacogenetics of the DNA repair pathways in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy. Cancer Lett. 353:160–166. 2014. View Article : Google Scholar : PubMed/NCBI
28	Zhang L, Gao G, Li X, Ren S, Li A, Xu J, Zhang J and Zhou C: Association between single nucleotide polymorphisms (SNPs) and toxicity of advanced non-small-cell lung cancer patients treated with chemotherapy. PLoS One. 7:e483502012. View Article : Google Scholar : PubMed/NCBI
29	Song X, Wang S, Hong X, Li X, Zhao X, Huai C, Chen H, Gao Z, Qian J, Wang J, et al: Single nucleotide polymorphisms of nucleotide excision repair pathway are significantly associated with outcomes of platinum-based chemotherapy in lung cancer. Sci Rep. 7:117852017. View Article : Google Scholar : PubMed/NCBI